Mixed J&J earnings leave investors little to cheer
NEW YORK — Investors grew cautious Tuesday after quarterly sales at Johnson & Johnson fell short of expectations and an influential analyst stirred worries that bank shares are overheated.
Most stocks posted modest losses, a day after major indexes finished at their best levels in a year. The Dow Jones industrial average slipped 15 points, though the Nasdaq composite index edged higher.
Stocks could get a bounce Wednesday from Intel Corp., which posted earnings and sales after the closing bell that topped expectations. The leading chipmaker also said business is improving. The stock rose 4 percent in after-hours trading.
The market could also get a lift from comments by CSX Corp. CEO Michael J. Ward, who said the worst of the recession “is likely behind us” as the major rail operator reported quarterly results after the bell. Still looming ahead is the first earnings report from a major bank early Wednesday, JPMorgan Chase & Corp.
J&J was the first in a series of big companies to report quarterly results this week, and a 5 percent drop in sales at the maker of health care products fanned concerns that companies have had to rely on cost-cutting to boost profits, as they did in the first half of the year. Investors are worried that earnings will suffer if sales don’t improve.
The market’s unease intensified after banking analyst Meredith Whitney lowered her rating on Goldman Sachs Group Inc. to “neutral” from “buy.” Goldman’s stock had risen 34 percent since Whitney upgraded the stock to “buy” in mid-July. The bank reports results on Thursday.
Health care stocks stumbled after J&J’s report and as the Senate Finance committee approved a version of the health care overhaul bill.
There were some pockets of green on trading screens. An agreement by Cisco Systems Inc., which makes computer networking gear, to buy Starent Networks Corp. for $2.9 billion lifted shares of technology companies.
The modest scale of the day’s slide suggested that traders are afraid of walking away from a market that has spent little time in reverse since bouncing off 12-year lows seven months ago.
Earnings reports are likely to continue to shape the market’s sentiment for the rest of this week.
“The market only makes sense at these levels if earnings can grow at a decent pace,” said Jerry Webman, chief economist at OppenheimerFunds Inc. “What we’re hearing now is OK, but you don’t get long-term earnings growth out of cost cutting.”
The Dow fell 14.74, or 0.2 percent, to 9,871.06. On Monday, it came within 69 points of the psychological barrier of 10,000, a level not seen in a year.
The Standard & Poor’s 500 index fell 3.00, or 0.3 percent, to 1,073.19, its first loss after six days of gains. The Nasdaq rose 0.75, or less than 0.1 percent, to 2,139.89.
Linda Duessel, equity market strategist at Federated Investors, said stocks could drift after the strong rally. “I don’t know if we have to pull back so much as take a break,” she said.
Investors have sent stocks higher in recent days on hopes that third-quarter earnings reports will signal that the economy is improving.
Goldman Sachs, Citigroup Inc. and Bank of America Corp. also report this week. Goldman fell $2.92, or 1.5 percent, to $187.23 after the downgrade.
Howard Ward, portfolio manager for GAMCO Growth Fund in Rye, N.Y., said investors are likely to lock in some profits following a rally that propelled the S&P 500 index up 58.6 percent since March and that future gains will be more modest.
“The market is going to be grinding its way higher from here,” he said. “The fire sale is over.”
Among stocks, Johnson & Johnson fell $1.52, or 2.4 percent, to $61.01.
The ICE Futures U.S. dollar index, which measures the dollar against other major currencies, dropped to a 14-month low. Gold subsequently hit a record high $1,069.70 an ounce, while oil rose 88 cents to settle at $74.15 a barrel on the New York Mercantile Exchange.
Bond prices rose, pushing yields down, after steep losses from last week. The yield on the benchmark 10-year Treasury note fell to 3.35 percent from 3.38 percent late Friday. Bond markets were closed Monday.
Three stocks fell for every two that rose on the New York Stock Exchange, where consolidated volume came to 4.4 billion shares compared with 3.8 billion Monday, when volume was much thinner because of the Columbus Day holiday.
The Russell 2000 index of smaller companies fell 2.11, or 0.3 percent, to 611.70.
Britain’s FTSE 100 fell 1.1 percent, while Germany’s DAX index and France’s CAC-40 each fell 1.2 percent. Japan’s Nikkei stock average rose 0.6 percent.
Related News
Stocks trade mixed as J&J posts mixed results; Cisco deal lifts some tech sharesOctober 13th, 2009 Stocks zigzag after Johnson & Johnson reportNEW YORK — Stocks are fluctuating following a mixed earnings report from Johnson & Johnson put a damper on hopes that sales were rebounding at big U.S. companies. The health care products maker said its sales fell more than expected.
Stocks drift lower as J&J posts mixed results; Cisco deal lifts technology sharesOctober 13th, 2009 Stocks drift lower after Johnson & Johnson reportNEW YORK — Stocks retreated from their highest levels in a year Tuesday after a mixed earnings report from Johnson & Johnson. The health care products maker, the first among a number of key companies to issue quarterly results this week, said sales fell 5 percent in the third quarter, a steeper drop than expected.
Bob Marley keyboardist Wycliffe "Steely" Johnson dies in NY at 47; produced dancehall hitsSeptember 6th, 2009 Bob Marley keyboardist dies in NY at 47NEW YORK — Jamaican reggae producer Wycliffe "Steely" Johnson, a keyboardist for Bob Marley, has died in New York at age 47. Fellow producer Cleveland "Clevie" Browne says Johnson died Tuesday at Brookhaven Memorial Hospital on Long Island, following a heart attack.
Federal appeals court revives whistle-blower suit alleging J&J illegally marketed anemia drugAugust 13th, 2009 Federal court OKs suit alleging illegal J&J salesBOSTON — A federal appeals court has revived a multibillion-dollar Medicare fraud case brought by whistle-blowers alleging Johnson & Johnson paid doctors kickbacks to wrongly prescribe an expensive drug. Two former salespeople for the health care giant allege J&J illegally marketed its blockbuster anemia drug Procrit.
Elan's losses narrow as sales of MS-fighting drug Tysabri growJuly 21st, 2009 Elan's 2Q loss narrows as MS drug sales growDUBLIN — Losses are narrowing at Elan Corp. PLC as sales of its key drug, the multiple sclerosis-fighting Tysabri, keep growing in the United States and Europe, the Irish biopharmaceutical company reported Tuesday.
Johnson Controls says income fell 63 percent in fiscal 3rd quarterJuly 20th, 2009 Johnson Controls income fell 63 percent in 3QMILWAUKEE — Johnson Controls Inc. said Monday its fiscal third-quarter earnings fell 63 percent, despite cost cutting to control expenses amid weakened economic conditions.
Johnson Controls says income falls 63 percent in fiscal 3rd quarterJuly 20th, 2009 Johnson Controls income falls 63 percent in 3QMILWAUKEE — Johnson Controls says its fiscal third-quarter earnings fell 63 percent, even though the auto parts and building products maker cut costs to control expenses amid weakened economic conditions. The Milwaukee-based company posted income of $163 million, or 26 cents per share, compared with $439 million, or 73 cents per share, in the same quarter a year ago.
Earnings roundup: Hi-Tech Pharmacal profit jumps, Johnson & Johnson net slips with drug salesJuly 14th, 2009 Earnings roundup: Hi-Tech Pharmacal, J&JAmong the earnings stories for Tuesday, July 14, from AP Financial News:
AMITYVILLE, N.Y. (AP) — Generic drug developer Hi-Tech Pharmacal Inc.
Obama nominates son of SD Sen. Tim Johnson to be US attorneyJuly 11th, 2009 Obama picks SD senator's son as US attorneyWASHINGTON — President Barack Obama nominated Brendan Johnson, the 34-year-old son of Sen. Tim Johnson, D-S.D., on Friday to serve as U.S.
How the Dow Jones industrials and other major stock indexes fared in Tuesday's tradingJune 2nd, 2009 How the major stock indexes fared on TuesdayInvestors grew cautious Tuesday after quarterly sales at Johnson & Johnson fell short of expectations and an influential analyst stirred worries that bank shares are overheated. Most stocks posted modest losses, a day after finishing at their best levels in a year.
Harden solid, Johnson has 3 RBIs to lead Chicago Cubs over Houston Astros 6-3May 8th, 2009 Harden pitches into 8th, Cubs beat Astros 6-3HOUSTON — Rich Harden pitched into the eighth inning and Reed Johnson hit a bases-loaded triple Wednesday night to lead the Chicago Cubs over the Houston Astros 6-3. Aramis Ramirez added a solo home run for the Cubs, who have won five of six.
Tiger falters late again, leaving Johnson in the lead at Quail HollowMay 3rd, 2009 Johnson emerges with a 2-shot lead at Quail HollowCHARLOTTE, N.C. — Tiger Woods dropped out of the lead with late bogeys for the second straight day, leaving former Masters champion Zach Johnson with a two-shot advantage Saturday heading into the final round of the Quail Hollow Championship.
Eagles defensive coordinator Jim Johnson coaches during cancer treatment, says he feels 'good'May 2nd, 2009 Eagles' Johnson coaches during cancer treatmentPHILADELPHIA — Philadelphia Eagles defensive coordinator Jim Johnson has continued to perform his duties while undergoing treatment for skin cancer and says he's feeling "good" and enjoying his work. Johnson is using a cart to traverse the fields while the Eagles hold their first minicamp of the offseason.
Slumping Kelly Johnson held out of Braves' lineup for second straight game against CardinalsApril 30th, 2009 Johnson held out of Braves' lineup againATLANTA — Slumping second baseman Kelly Johnson was held out of the Atlanta Braves' starting lineup for the second straight day. Braves manager Bobby Cox gave Omar Infante his second straight start for Johnson, who is hitting .203, in Wednesday night's game against St.
Bengals sign FB Jeremi Johnson, who sat out 2008 season with injuryApril 24th, 2009 Bengals sign FB Jeremi JohnsonCINCINNATI — The Cincinnati Bengals have signed fullback Jeremi Johnson, a regular for five seasons before sitting out last season with an injury. Terms were not released.